Home > > > Report Detail

Peptide Antibiotics - Global Market Insights and Sales Trends 2024

Publisher Name :
Date: 25-Dec-2023
No. of pages: 103
Inquire Before Buying

The global Peptide Antibiotics market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Peptide Antibiotics in various end use industries. The expanding demands from the Pharma & Healthcare, Food Industry, Commodities and Other, are propelling Peptide Antibiotics market. Ribosomal Synthesized Peptide Antibiotics, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Non-Ribosomally Synthesized Peptide Antibiotics segment is estimated at % CAGR for the next seven-year period.

Asia Pacific shows high growth potential for Peptide Antibiotics market, driven by demand from China, the second largest economy with some signs of stabilising, the Peptide Antibiotics market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.

Report Objectives

This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Peptide Antibiotics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Peptide Antibiotics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Peptide Antibiotics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Peptide Antibiotics sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Peptide Antibiotics covered in this report include Pfizer, Novartis, GlaxoSmithKline, Eli Lilly, Theravance, Vicuron Pharmaceuticals, Savara Pharmaceuticals, AMP Therapeutics and Hospira, etc.

The global Peptide Antibiotics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

- Pfizer

- Novartis

- GlaxoSmithKline

- Eli Lilly

- Theravance

- Vicuron Pharmaceuticals

- Savara Pharmaceuticals

- AMP Therapeutics

- Hospira

- Kasten

- Madam Therapeutics

- Phosphagenics

- Pacgen Life Science Corporation

Global Peptide Antibiotics market, By Region:

- North America (U.S., Canada, Mexico)

- Europe (Germany, France, UK, Italy, etc.)

- Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

- South America (Brazil, etc.)

- Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

Global Peptide Antibiotics market, Segment by Type:

- Ribosomal Synthesized Peptide Antibiotics

- Non-Ribosomally Synthesized Peptide Antibiotics

Global Peptide Antibiotics market, by Application

- Pharma & Healthcare

- Food Industry

- Commodities

- Other

Core Chapters

Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter Two: Detailed analysis of Peptide Antibiotics manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter Three: Sales, revenue of Peptide Antibiotics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter Twelve: Analysis of sales channel, distributors and customers.

Chapter Thirteen: Research Findings and Conclusion.

Peptide Antibiotics - Global Market Insights and Sales Trends 2024

Table of Contents
1 Peptide Antibiotics Market Overview
1.1 Peptide Antibiotics Product Overview
1.2 Peptide Antibiotics Market Segment by Type
1.2.1 Ribosomal Synthesized Peptide Antibiotics
1.2.2 Non-Ribosomally Synthesized Peptide Antibiotics
1.3 Global Peptide Antibiotics Market Size by Type
1.3.1 Global Peptide Antibiotics Market Size Overview by Type (2018-2029)
1.3.2 Global Peptide Antibiotics Historic Market Size Review by Type (2018-2023)
1.3.3 Global Peptide Antibiotics Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Peptide Antibiotics Sales Breakdown by Type (2018-2023)
1.4.2 Europe Peptide Antibiotics Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Peptide Antibiotics Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Peptide Antibiotics Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Peptide Antibiotics Sales Breakdown by Type (2018-2023)
2 Global Peptide Antibiotics Market Competition by Company
2.1 Global Top Players by Peptide Antibiotics Sales (2018-2023)
2.2 Global Top Players by Peptide Antibiotics Revenue (2018-2023)
2.3 Global Top Players by Peptide Antibiotics Price (2018-2023)
2.4 Global Top Manufacturers Peptide Antibiotics Manufacturing Base Distribution, Sales Area, Product Type
2.5 Peptide Antibiotics Market Competitive Situation and Trends
2.5.1 Peptide Antibiotics Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Peptide Antibiotics Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Peptide Antibiotics as of 2022)
2.7 Date of Key Manufacturers Enter into Peptide Antibiotics Market
2.8 Key Manufacturers Peptide Antibiotics Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Peptide Antibiotics Status and Outlook by Region
3.1 Global Peptide Antibiotics Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Peptide Antibiotics Historic Market Size by Region
3.2.1 Global Peptide Antibiotics Sales in Volume by Region (2018-2023)
3.2.2 Global Peptide Antibiotics Sales in Value by Region (2018-2023)
3.2.3 Global Peptide Antibiotics Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Peptide Antibiotics Forecasted Market Size by Region
3.3.1 Global Peptide Antibiotics Sales in Volume by Region (2024-2029)
3.3.2 Global Peptide Antibiotics Sales in Value by Region (2024-2029)
3.3.3 Global Peptide Antibiotics Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Peptide Antibiotics by Application
4.1 Peptide Antibiotics Market Segment by Application
4.1.1 Pharma & Healthcare
4.1.2 Food Industry
4.1.3 Commodities
4.1.4 Other
4.2 Global Peptide Antibiotics Market Size by Application
4.2.1 Global Peptide Antibiotics Market Size Overview by Application (2018-2029)
4.2.2 Global Peptide Antibiotics Historic Market Size Review by Application (2018-2023)
4.2.3 Global Peptide Antibiotics Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Peptide Antibiotics Sales Breakdown by Application (2018-2023)
4.3.2 Europe Peptide Antibiotics Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Peptide Antibiotics Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Peptide Antibiotics Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Peptide Antibiotics Sales Breakdown by Application (2018-2023)
5 North America Peptide Antibiotics by Country
5.1 North America Peptide Antibiotics Historic Market Size by Country
5.1.1 North America Peptide Antibiotics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Peptide Antibiotics Sales in Volume by Country (2018-2023)
5.1.3 North America Peptide Antibiotics Sales in Value by Country (2018-2023)
5.2 North America Peptide Antibiotics Forecasted Market Size by Country
5.2.1 North America Peptide Antibiotics Sales in Volume by Country (2024-2029)
5.2.2 North America Peptide Antibiotics Sales in Value by Country (2024-2029)
6 Europe Peptide Antibiotics by Country
6.1 Europe Peptide Antibiotics Historic Market Size by Country
6.1.1 Europe Peptide Antibiotics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Peptide Antibiotics Sales in Volume by Country (2018-2023)
6.1.3 Europe Peptide Antibiotics Sales in Value by Country (2018-2023)
6.2 Europe Peptide Antibiotics Forecasted Market Size by Country
6.2.1 Europe Peptide Antibiotics Sales in Volume by Country (2024-2029)
6.2.2 Europe Peptide Antibiotics Sales in Value by Country (2024-2029)
7 Asia-Pacific Peptide Antibiotics by Region
7.1 Asia-Pacific Peptide Antibiotics Historic Market Size by Region
7.1.1 Asia-Pacific Peptide Antibiotics Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Peptide Antibiotics Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Peptide Antibiotics Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Peptide Antibiotics Forecasted Market Size by Region
7.2.1 Asia-Pacific Peptide Antibiotics Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Peptide Antibiotics Sales in Value by Region (2024-2029)
8 Latin America Peptide Antibiotics by Country
8.1 Latin America Peptide Antibiotics Historic Market Size by Country
8.1.1 Latin America Peptide Antibiotics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Peptide Antibiotics Sales in Volume by Country (2018-2023)
8.1.3 Latin America Peptide Antibiotics Sales in Value by Country (2018-2023)
8.2 Latin America Peptide Antibiotics Forecasted Market Size by Country
8.2.1 Latin America Peptide Antibiotics Sales in Volume by Country (2024-2029)
8.2.2 Latin America Peptide Antibiotics Sales in Value by Country (2024-2029)
9 Middle East and Africa Peptide Antibiotics by Country
9.1 Middle East and Africa Peptide Antibiotics Historic Market Size by Country
9.1.1 Middle East and Africa Peptide Antibiotics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Peptide Antibiotics Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Peptide Antibiotics Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Peptide Antibiotics Forecasted Market Size by Country
9.2.1 Middle East and Africa Peptide Antibiotics Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Peptide Antibiotics Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Information
10.1.2 Pfizer Introduction and Business Overview
10.1.3 Pfizer Peptide Antibiotics Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Pfizer Peptide Antibiotics Products Offered
10.1.5 Pfizer Recent Development
10.2 Novartis
10.2.1 Novartis Company Information
10.2.2 Novartis Introduction and Business Overview
10.2.3 Novartis Peptide Antibiotics Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Novartis Peptide Antibiotics Products Offered
10.2.5 Novartis Recent Development
10.3 GlaxoSmithKline
10.3.1 GlaxoSmithKline Company Information
10.3.2 GlaxoSmithKline Introduction and Business Overview
10.3.3 GlaxoSmithKline Peptide Antibiotics Sales, Revenue and Gross Margin (2018-2023)
10.3.4 GlaxoSmithKline Peptide Antibiotics Products Offered
10.3.5 GlaxoSmithKline Recent Development
10.4 Eli Lilly
10.4.1 Eli Lilly Company Information
10.4.2 Eli Lilly Introduction and Business Overview
10.4.3 Eli Lilly Peptide Antibiotics Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Eli Lilly Peptide Antibiotics Products Offered
10.4.5 Eli Lilly Recent Development
10.5 Theravance
10.5.1 Theravance Company Information
10.5.2 Theravance Introduction and Business Overview
10.5.3 Theravance Peptide Antibiotics Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Theravance Peptide Antibiotics Products Offered
10.5.5 Theravance Recent Development
10.6 Vicuron Pharmaceuticals
10.6.1 Vicuron Pharmaceuticals Company Information
10.6.2 Vicuron Pharmaceuticals Introduction and Business Overview
10.6.3 Vicuron Pharmaceuticals Peptide Antibiotics Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Vicuron Pharmaceuticals Peptide Antibiotics Products Offered
10.6.5 Vicuron Pharmaceuticals Recent Development
10.7 Savara Pharmaceuticals
10.7.1 Savara Pharmaceuticals Company Information
10.7.2 Savara Pharmaceuticals Introduction and Business Overview
10.7.3 Savara Pharmaceuticals Peptide Antibiotics Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Savara Pharmaceuticals Peptide Antibiotics Products Offered
10.7.5 Savara Pharmaceuticals Recent Development
10.8 AMP Therapeutics
10.8.1 AMP Therapeutics Company Information
10.8.2 AMP Therapeutics Introduction and Business Overview
10.8.3 AMP Therapeutics Peptide Antibiotics Sales, Revenue and Gross Margin (2018-2023)
10.8.4 AMP Therapeutics Peptide Antibiotics Products Offered
10.8.5 AMP Therapeutics Recent Development
10.9 Hospira
10.9.1 Hospira Company Information
10.9.2 Hospira Introduction and Business Overview
10.9.3 Hospira Peptide Antibiotics Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Hospira Peptide Antibiotics Products Offered
10.9.5 Hospira Recent Development
10.10 Kasten
10.10.1 Kasten Company Information
10.10.2 Kasten Introduction and Business Overview
10.10.3 Kasten Peptide Antibiotics Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Kasten Peptide Antibiotics Products Offered
10.10.5 Kasten Recent Development
10.11 Madam Therapeutics
10.11.1 Madam Therapeutics Company Information
10.11.2 Madam Therapeutics Introduction and Business Overview
10.11.3 Madam Therapeutics Peptide Antibiotics Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Madam Therapeutics Peptide Antibiotics Products Offered
10.11.5 Madam Therapeutics Recent Development
10.12 Phosphagenics
10.12.1 Phosphagenics Company Information
10.12.2 Phosphagenics Introduction and Business Overview
10.12.3 Phosphagenics Peptide Antibiotics Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Phosphagenics Peptide Antibiotics Products Offered
10.12.5 Phosphagenics Recent Development
10.13 Pacgen Life Science Corporation
10.13.1 Pacgen Life Science Corporation Company Information
10.13.2 Pacgen Life Science Corporation Introduction and Business Overview
10.13.3 Pacgen Life Science Corporation Peptide Antibiotics Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Pacgen Life Science Corporation Peptide Antibiotics Products Offered
10.13.5 Pacgen Life Science Corporation Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Peptide Antibiotics Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Peptide Antibiotics Industrial Chain Analysis
11.4 Peptide Antibiotics Market Dynamics
11.4.1 Peptide Antibiotics Industry Trends
11.4.2 Peptide Antibiotics Market Drivers
11.4.3 Peptide Antibiotics Market Challenges
11.4.4 Peptide Antibiotics Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Peptide Antibiotics Distributors
12.3 Peptide Antibiotics Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Major Company of Ribosomal Synthesized Peptide Antibiotics
Table 2. Major Company of Non-Ribosomally Synthesized Peptide Antibiotics
Table 3. Global Peptide Antibiotics Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 4. Global Peptide Antibiotics Sales by Type (2018-2023) & (MT)
Table 5. Global Peptide Antibiotics Sales Market Share in Volume by Type (2018-2023)
Table 6. Global Peptide Antibiotics Sales by Type (2018-2023) & (US& Million)
Table 7. Global Peptide Antibiotics Market Share in Value by Type (2018-2023)
Table 8. Global Peptide Antibiotics Price by Type (2018-2023) & (USD/Kg)
Table 9. Global Peptide Antibiotics Sales by Type (2024-2029) & (MT)
Table 10. Global Peptide Antibiotics Sales Market Share in Volume by Type (2024-2029)
Table 11. Global Peptide Antibiotics Sales by Type (2024-2029) & (US$ Million)
Table 12. Global Peptide Antibiotics Sales Market Share in Value by Type (2024-2029)
Table 13. Global Peptide Antibiotics Price by Type (2024-2029) & (USD/Kg)
Table 14. North America Peptide Antibiotics Sales by Type (2018-2023) & (MT)
Table 15. North America Peptide Antibiotics Sales by Type (2018-2023) & (US$ Million)
Table 16. Europe Peptide Antibiotics Sales (MT) by Type (2018-2023)
Table 17. Europe Peptide Antibiotics Sales by Type (2018-2023) & (US$ Million)
Table 18. Asia-Pacific Peptide Antibiotics Sales (MT) by Type (2018-2023)
Table 19. Asia-Pacific Peptide Antibiotics Sales by Type (2018-2023) & (US$ Million)
Table 20. Latin America Peptide Antibiotics Sales (MT) by Type (2018-2023)
Table 21. Latin America Peptide Antibiotics Sales by Type (2018-2023) & (US$ Million)
Table 22. Middle East and Africa Peptide Antibiotics Sales (MT) by Type (2018-2023)
Table 23. Middle East and Africa Peptide Antibiotics Sales by Type (2018-2023) & (US$ Million)
Table 24. Global Peptide Antibiotics Sales by Company (2018-2023) & (MT)
Table 25. Global Peptide Antibiotics Sales Share by Company (2018-2023)
Table 26. Global Peptide Antibiotics Revenue by Company (2018-2023) & (US$ Million)
Table 27. Global Peptide Antibiotics Revenue Share by Company (2018-2023)
Table 28. Global Market Peptide Antibiotics Price by Company (2018-2023) & (USD/Kg)
Table 29. Global Peptide Antibiotics Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Peptide Antibiotics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Peptide Antibiotics as of 2022)
Table 32. Date of Key Manufacturers Enter into Peptide Antibiotics Market
Table 33. Key Manufacturers Peptide Antibiotics Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Peptide Antibiotics Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 36. Global Peptide Antibiotics Sales by Region (2018-2023) & (MT)
Table 37. Global Peptide Antibiotics Sales Market Share in Volume by Region (2018-2023)
Table 38. Global Peptide Antibiotics Sales by Region (2018-2023) & (US$ Million)
Table 39. Global Peptide Antibiotics Sales Market Share in Value by Region (2018-2023)
Table 40. Global Peptide Antibiotics Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 41. Global Peptide Antibiotics Sales by Region (2024-2029) & (MT)
Table 42. Global Peptide Antibiotics Sales Market Share in Volume by Region (2024-2029)
Table 43. Global Peptide Antibiotics Sales by Region (2024-2029) & (US$ Million)
Table 44. Global Peptide Antibiotics Sales Market Share in Value by Region (2024-2029)
Table 45. Global Peptide Antibiotics Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2024-2029)
Table 46. Global Peptide Antibiotics Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 47. Global Peptide Antibiotics Sales by Application (2018-2023) & (MT)
Table 48. Global Peptide Antibiotics Sales Market Share in Volume by Application (2018-2023)
Table 49. Global Peptide Antibiotics Sales by Application (2018-2023) & (US$ Million)
Table 50. Global Peptide Antibiotics Sales Market Share in Value by Application (2018-2023)
Table 51. Global Peptide Antibiotics Price by Application (2018-2023) & (USD/Kg)
Table 52. Global Peptide Antibiotics Sales by Application (2024-2029) & (MT)
Table 53. Global Peptide Antibiotics Sales Market Share in Volume by Application (2024-2029)
Table 54. Global Peptide Antibiotics Sales by Application (2024-2029) & (US$ Million)
Table 55. Global Peptide Antibiotics Sales Market Share in Value by Application (2024-2029)
Table 56. Global Peptide Antibiotics Price by Application (2024-2029) & (USD/Kg)
Table 57. North America Peptide Antibiotics Sales by Application (2018-2023) (MT)
Table 58. North America Peptide Antibiotics Sales by Application (2018-2023) & (US$ Million)
Table 59. Europe Peptide Antibiotics Sales by Application (2018-2023) (MT)
Table 60. Europe Peptide Antibiotics Sales by Application (2018-2023) & (US$ Million)
Table 61. Asia-Pacific Peptide Antibiotics Sales by Application (2018-2023) (MT)
Table 62. Asia-Pacific Peptide Antibiotics Sales by Application (2018-2023) & (US$ Million)
Table 63. Latin America Peptide Antibiotics Sales by Application (2018-2023) (MT)
Table 64. Latin America Peptide Antibiotics Sales by Application (2018-2023) & (US$ Million)
Table 65. Middle East and Africa Peptide Antibiotics Sales by Application (2018-2023) (MT)
Table 66. Middle East and Africa Peptide Antibiotics Sales by Application (2018-2023) & (US$ Million)
Table 67. North America Peptide Antibiotics Sales by Country (2018-2023) & (MT)
Table 68. North America Peptide Antibiotics Sales Market Share in Volume by Country (2018-2023)
Table 69. North America Peptide Antibiotics Sales by Country (2018-2023) & (US$ Million)
Table 70. North America Peptide Antibiotics Sales Market Share in Value by Country (2018-2023)
Table 71. North America Peptide Antibiotics Sales by Country (2024-2029) & (MT)
Table 72. North America Peptide Antibiotics Sales Market Share in Volume by Country (2024-2029)
Table 73. North America Peptide Antibiotics Sales by Country (2024-2029) & (US$ Million)
Table 74. North America Peptide Antibiotics Sales Market Share in Value by Country (2024-2029)
Table 75. Europe Peptide Antibiotics Sales by Country (2018-2023) & (MT)
Table 76. Europe Peptide Antibiotics Sales Market Share in Volume by Country (2018-2023)
Table 77. Europe Peptide Antibiotics Sales by Country (2018-2023) & (US$ Million)
Table 78. Europe Peptide Antibiotics Sales Market Share in Value by Country (2018-2023)
Table 79. Europe Peptide Antibiotics Sales by Country (2024-2029) & (MT)
Table 80. Europe Peptide Antibiotics Sales Market Share in Volume by Country (2024-2029)
Table 81. Europe Peptide Antibiotics Sales by Country (2024-2029) & (US$ Million)
Table 82. Europe Peptide Antibiotics Sales Market Share in Value by Country (2024-2029)
Table 83. Asia-Pacific Peptide Antibiotics Sales by Region (2018-2023) & (MT)
Table 84. Asia-Pacific Peptide Antibiotics Sales Market Share in Volume by Region (2018-2023)
Table 85. Asia-Pacific Peptide Antibiotics Sales by Region (2018-2023) & (US$ Million)
Table 86. Asia-Pacific Peptide Antibiotics Sales Market Share in Value by Region (2018-2023)
Table 87. Asia-Pacific Peptide Antibiotics Sales by Region (2024-2029) & (MT)
Table 88. Asia-Pacific Peptide Antibiotics Sales Market Share in Volume by Region (2024-2029)
Table 89. Asia-Pacific Peptide Antibiotics Sales by Region (2024-2029) & (US$ Million)
Table 90. Asia-Pacific Peptide Antibiotics Sales Market Share in Value by Region (2024-2029)
Table 91. Latin America Peptide Antibiotics Sales by Country (2018-2023) & (MT)
Table 92. Latin America Peptide Antibiotics Sales Market Share in Volume by Country (2018-2023)
Table 93. Latin America Peptide Antibiotics Sales by Country (2018-2023) & (US$ Million)
Table 94. Latin America Peptide Antibiotics Sales Market Share in Value by Country (2018-2023)
Table 95. Latin America Peptide Antibiotics Sales by Country (2024-2029) & (MT)
Table 96. Latin America Peptide Antibiotics Sales Market Share in Volume by Country (2024-2029)
Table 97. Latin America Peptide Antibiotics Sales by Country (2024-2029) & (US$ Million)
Table 98. Latin America Peptide Antibiotics Sales Market Share in Value by Country (2024-2029)
Table 99. Middle East and Africa Peptide Antibiotics Sales by Country (2018-2023) & (MT)
Table 100. Middle East and Africa Peptide Antibiotics Sales Market Share in Volume by Country (2018-2023)
Table 101. Middle East and Africa Peptide Antibiotics Sales by Country (2018-2023) & (US$ Million)
Table 102. Middle East and Africa Peptide Antibiotics Sales Market Share in Value by Country (2018-2023)
Table 103. Middle East and Africa Peptide Antibiotics Sales by Country (2024-2029) & (MT)
Table 104. Middle East and Africa Peptide Antibiotics Sales Market Share in Volume by Country (2024-2029)
Table 105. Middle East and Africa Peptide Antibiotics Sales by Country (2024-2029) & (US$ Million)
Table 106. Middle East and Africa Peptide Antibiotics Sales Market Share in Value by Country (2024-2029)
Table 107. Pfizer Company Information
Table 108. Pfizer Introduction and Business Overview
Table 109. Pfizer Peptide Antibiotics Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2023)
Table 110. Pfizer Peptide Antibiotics Product
Table 111. Pfizer Recent Development
Table 112. Novartis Company Information
Table 113. Novartis Introduction and Business Overview
Table 114. Novartis Peptide Antibiotics Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2023)
Table 115. Novartis Peptide Antibiotics Product
Table 116. Novartis Recent Development
Table 117. GlaxoSmithKline Company Information
Table 118. GlaxoSmithKline Introduction and Business Overview
Table 119. GlaxoSmithKline Peptide Antibiotics Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2023)
Table 120. GlaxoSmithKline Peptide Antibiotics Product
Table 121. GlaxoSmithKline Recent Development
Table 122. Eli Lilly Company Information
Table 123. Eli Lilly Introduction and Business Overview
Table 124. Eli Lilly Peptide Antibiotics Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2023)
Table 125. Eli Lilly Peptide Antibiotics Product
Table 126. Eli Lilly Recent Development
Table 127. Theravance Company Information
Table 128. Theravance Introduction and Business Overview
Table 129. Theravance Peptide Antibiotics Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2023)
Table 130. Theravance Peptide Antibiotics Product
Table 131. Theravance Recent Development
Table 132. Vicuron Pharmaceuticals Company Information
Table 133. Vicuron Pharmaceuticals Introduction and Business Overview
Table 134. Vicuron Pharmaceuticals Peptide Antibiotics Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2023)
Table 135. Vicuron Pharmaceuticals Peptide Antibiotics Product
Table 136. Vicuron Pharmaceuticals Recent Development
Table 137. Savara Pharmaceuticals Company Information
Table 138. Savara Pharmaceuticals Introduction and Business Overview
Table 139. Savara Pharmaceuticals Peptide Antibiotics Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2023)
Table 140. Savara Pharmaceuticals Peptide Antibiotics Product
Table 141. Savara Pharmaceuticals Recent Development
Table 142. AMP Therapeutics Company Information
Table 143. AMP Therapeutics Introduction and Business Overview
Table 144. AMP Therapeutics Peptide Antibiotics Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2023)
Table 145. AMP Therapeutics Peptide Antibiotics Product
Table 146. AMP Therapeutics Recent Development
Table 147. Hospira Company Information
Table 148. Hospira Introduction and Business Overview
Table 149. Hospira Peptide Antibiotics Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2023)
Table 150. Hospira Peptide Antibiotics Product
Table 151. Hospira Recent Development
Table 152. Kasten Company Information
Table 153. Kasten Introduction and Business Overview
Table 154. Kasten Peptide Antibiotics Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2023)
Table 155. Kasten Peptide Antibiotics Product
Table 156. Kasten Recent Development
Table 157. Madam Therapeutics Company Information
Table 158. Madam Therapeutics Introduction and Business Overview
Table 159. Madam Therapeutics Peptide Antibiotics Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2023)
Table 160. Madam Therapeutics Peptide Antibiotics Product
Table 161. Madam Therapeutics Recent Development
Table 162. Phosphagenics Company Information
Table 163. Phosphagenics Introduction and Business Overview
Table 164. Phosphagenics Peptide Antibiotics Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2023)
Table 165. Phosphagenics Peptide Antibiotics Product
Table 166. Phosphagenics Recent Development
Table 167. Pacgen Life Science Corporation Company Information
Table 168. Pacgen Life Science Corporation Introduction and Business Overview
Table 169. Pacgen Life Science Corporation Peptide Antibiotics Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2023)
Table 170. Pacgen Life Science Corporation Peptide Antibiotics Product
Table 171. Pacgen Life Science Corporation Recent Development
Table 172. Key Raw Materials Lists
Table 173. Raw Materials Key Suppliers Lists
Table 174. Peptide Antibiotics Market Trends
Table 175. Peptide Antibiotics Market Drivers
Table 176. Peptide Antibiotics Market Challenges
Table 177. Peptide Antibiotics Market Restraints
Table 178. Peptide Antibiotics Distributors List
Table 179. Peptide Antibiotics Downstream Customers
Table 180. Research Programs/Design for This Report
Table 181. Key Data Information from Secondary Sources
Table 182. Key Data Information from Primary Sources
List of Figures
Figure 1. Peptide Antibiotics Product Picture
Figure 2. Global Peptide Antibiotics Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Peptide Antibiotics Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Peptide Antibiotics Sales Status and Outlook (2018-2029) & (MT)
Figure 5. Product Picture of Ribosomal Synthesized Peptide Antibiotics
Figure 6. Global Ribosomal Synthesized Peptide Antibiotics Sales YoY Growth (2018-2029) & (MT)
Figure 7. Product Picture of Non-Ribosomally Synthesized Peptide Antibiotics
Figure 8. Global Non-Ribosomally Synthesized Peptide Antibiotics Sales YoY Growth (2018-2029) & (MT)
Figure 9. Global Peptide Antibiotics Sales by Type (2018-2029) & (US$ Million)
Figure 10. Global Peptide Antibiotics Sales Market Share by Type in 2022 & 2029
Figure 11. North America Peptide Antibiotics Sales Market Share in Volume by Type in 2022
Figure 12. North America Peptide Antibiotics Sales Market Share in Value by Type in 2022
Figure 13. Europe Peptide Antibiotics Sales Market Share in Volume by Type in 2022
Figure 14. Europe Peptide Antibiotics Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Peptide Antibiotics Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Peptide Antibiotics Sales Market Share in Value by Type in 2022
Figure 17. Latin America Peptide Antibiotics Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Peptide Antibiotics Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Peptide Antibiotics Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Peptide Antibiotics Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Peptide Antibiotics Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Peptide Antibiotics Revenue in 2022
Figure 23. Peptide Antibiotics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Pharma & Healthcare
Figure 25. Global Pharma & Healthcare Sales YoY Growth (2018-2029) & (MT)
Figure 26. Product Picture of Food Industry
Figure 27. Global Food Industry Sales YoY Growth (2018-2029) & (MT)
Figure 28. Product Picture of Commodities
Figure 29. Global Commodities Sales YoY Growth (2018-2029) & (MT)
Figure 30. Product Picture of Other
Figure 31. Global Other Sales YoY Growth (2018-2029) & (MT)
Figure 32. Global Peptide Antibiotics Sales by Application (2018-2029) & (US$ Million)
Figure 33. Global Peptide Antibiotics Sales Market Share by Application in 2022 & 2029
Figure 34. North America Peptide Antibiotics Sales Market Share in Volume by Application in 2022
Figure 35. North America Peptide Antibiotics Sales Market Share in Value by Application in 2022
Figure 36. Europe Peptide Antibiotics Sales Market Share in Volume by Application in 2022
Figure 37. Europe Peptide Antibiotics Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific Peptide Antibiotics Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific Peptide Antibiotics Sales Market Share in Value by Application in 2022
Figure 40. Latin America Peptide Antibiotics Sales Market Share in Volume by Application in 2022
Figure 41. Latin America Peptide Antibiotics Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa Peptide Antibiotics Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. Peptide Antibiotics Manufacturing Cost Structure
Figure 45. Peptide Antibiotics Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs